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Materials and Methods 
 
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
or nitrogen atmosphere using dry, deoxygenated solvents. Solvents were dried by passage 
through an activated alumina column under argon. Commercially obtained reagents were 
used as received. Chemicals were purchased from Sigma Aldrich/Strem/Alfa 
Aesar/Oakwood Chemicals and used as received.  Reaction temperatures were controlled 
by an IKAmag temperature modulator. Glove box manipulations were performed under a 
nitrogen atmosphere. Thin-layer chromatography (TLC) and preparatory TLC was 
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performed using E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by 
UV fluorescence quenching, KMnO4, or p-anisaldehyde staining. SiliaFlash P60 
Academic Silica gel (particle size 0.040–0.063 mm) was used for flash chromatography. 
Analytical chiral HPLC was performed with an Agilent 1100 Series HPLC utilizing a 
Chiralpak IC column (4.6 mm x 25 cm) or a Chiralpak AD-H column (4.6 mm x 25 cm), 
both obtained from Daicel Chemical Industries, Ltd. with visualization at 210 nm. 
Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system utilizing a Chiralpak AD-H column (4.6 mm x 25 cm) obtained 
from Daicel Chemical Industries, Ltd. with visualization at 210 nm. Preparatory HPLC was 
performed with an Agilent 1200 Series HPLC equipped with a Viridis SFC 2-Ethylpyridine 
5 µm column (4.6 x 250 mm). 1H NMR spectra were recorded on a Bruker Avance HD 
400 MHz spectrometer and are reported relative to residual CHCl3  (δ 7.26 ppm). 13C NMR 
spectra were recorded on a Bruker Avance HD 400 MHz spectrometer and are reported 
relative to residual CDCl3  (δ 77.16 ppm). Data for 1H NMR are reported as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s 
= broad singlet. Data for 13C NMR are reported in terms of chemical shifts (δ ppm). Some 
reported spectra include minor solvent impurities of benzene (δ 7.36 ppm), water (δ 1.56 
ppm), ethyl acetate (δ 4.12, 2.05, 1.26 ppm), methylene chloride (δ 5.30 ppm), grease (δ 
1.26, 0.86 ppm), and/or silicon grease (δ 0.07 ppm), which do not impact product 
assignments. IR spectra were obtained using a Perkin Elmer Paragon 1000 spectrometer 
using thin films deposited on NaCl plates and reported in frequency of absorption (cm-1). 
High resolution mass spectra (HRMS) were obtained from the Caltech Mass Spectral 
Facility using a JEOL JMS-600H High Resolution Mass Spectrometer in fast atom 
bombardment (FAB+) or electron ionization (EI+) mode, or an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
Optical rotations were measured with a Jasco P-2000 polarimeter operating on the sodium 
D-line (589 nm), using a 100 mm pathlength cell and are reported as: [α]DT (concentration 
in g/100 mL, solvent).  
 
List of Abbreviations: ee – enantiomeric excess, HPLC – high-performance liquid 
chromatography, TLC – thin-layer chromatography, EtOAc – ethyl acetate, THF – 
tetrahydrofuran, MeOH – methanol, Et2O – diethyl ether, IPA – isopropanol, AcOH – 
acetic acid, DME – dimethoxyethane, TBD – 1,5,7-triazabicyclo[4.4.0]dec-5-ene, cod – 
cis,cis-1,5-cyclooctadiene, DIBAL – diisobutylaluminium hydride, dppp – 1,3-
bis(diphenylphosphino)propane, MAC – masked acyl cyanide, CSA – camphorsulfonic 
acid 
 
Preparation of Known Compounds: Previously reported methods were used to prepare 
ligands (S,Sa)-L11 and (Sa)-L32 as well as starting materials 13, 25, 54, 6a5, 6b6, 6d6, 6e6, 
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Representative Procedures for the Synthesis of Electrophiles 
 




Methyl (E)-3-(4-formylphenyl)but-2-enoate (SI-1). To a solution of (4-
formylphenyl)boronic acid (0.75 g, 5.0 mmol, 1 equiv), Pd(OAc)2 (23 mg, 0.10 mmol, 0.02 
equiv), dppp (62 mg, 0.15 mmol, 0.03 equiv) in acetone (8 mL) was added methyl crotonate 
(1.1 mL, 10.0 mmol, 2 equiv) followed by trifluoroacetic acid (0.12 mL, 1.5 mmol, 0.3 
equiv). The resulting slurry was heated under reflux for 48 h, whereupon the reaction was 
cooled to ambient temperature and concentrated under reduced pressure. The crude product 
was purified by silica gel flash column chromatography (5% EtOAc/hexanes) to give 
carbonate SI-1 as a colorless oil (0.17 g, 17% yield): 1H NMR (400 MHz, CDCl3) δ 10.06 
(s, 1H), 7.97 – 7.78 (m, 2H), 7.74 – 7.58 (m, 2H), 6.22 (q, J = 1.3 Hz, 1H), 3.80 (s, 3H), 
2.62 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 191.8, 167.0, 154.4, 148.2, 136.5, 
130.1, 127.1, 119.0, 51.5, 18.1; IR (Neat Film, NaCl) 2950, 2839, 1704, 1631, 1605, 1434, 
1349, 1273, 1214, 1171, 1036, 828 cm-1; HRMS (FAB+) m/z calc’d for C12H13O3 [M+H]+: 
205.0865, found 205.0860. 
 




(E)-3-(4-Fluorophenyl)but-2-en-1-yl methyl carbonate (6c). To a solution of methyl 
(E)-3-(4-fluorophenyl)but-2-enoate8 (0.30 g, 1.6 mmol, 1 equiv) in THF (3.1 mL) at –78 
°C was added DIBAL (0.85 mL, 4.8 mmol, 3 equiv) dropwise. The resulting reaction 
mixture was stirred at –78 °C for 2.5 h, whereupon the reaction was quenched with a 
saturated aqueous Rochelle’s salt solution (5 mL). The cooling bath was then removed and 
the reaction was stirred for 18 h at ambient temperature. The aqueous layer was extracted 
with CH2Cl2 (3 x 20 mL) and the combined organic layers were washed with brine (20 
mL), dried over Na2SO4, and concentrated under reduced pressure.   
 
The crude material was then dissolved in CH2Cl2 (6.4 mL) and cooled to 0 °C. Pyridine 
(1.1 mL, 13 mmol, 8.3 equiv) was added followed by methyl chloroformate (0.28 mL, 3.7 
mmol, 2.3 equiv) dropwise. The resulting solution was allowed to warm to ambient 
temperature and stirred for 18 h. The reaction was quenched with the addition of 1 M HCl 
(5 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The combined 
organic layers were washed with brine (20 mL), dried over Na2SO4, and concentrated under 
reduced pressure. The crude product was purified by silica gel flash column 
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38% yield): 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.33 (m, 2H), 7.05 – 6.96 (m, 2H), 5.87 
(tq, J = 7.0, 1.4 Hz, 1H), 4.84 (dd, J = 7.1, 0.8 Hz, 2H), 3.80 (s, 3H), 2.11 (dd, J = 1.4, 0.7 
Hz, 3H).; 13C NMR (101 MHz, CDCl3) δ 163.7, 161.3, 156.0, 140.2, 138.6 (d, J = 3.3 Hz), 
127.6 (d, J = 8.0 Hz), 120.7 (d, J = 1.3 Hz), 115.4, 115.1, 65.0, 55.0, 16.5; IR (Neat Film, 
NaCl) 2961, 1896, 1742, 1649, 1589, 1468, 1442, 1379, 1334, 1252, 1110, 994, 960, 945, 
825, 794 cm-1; HRMS (FAB+) m/z calc’d for C12H13FO3 [M]+: 224.0849, found 224.0850. 
 
 




(Z)-methyl (3-phenylbut-2-en-1-yl) carbonate (4). Carbonate 4 was prepared from ethyl 
(Z)-3-phenylbut-2-enoate9 according to Representative Procedure #2 and isolated by silica 
gel flash column chromatography (5% EtOAc/hexanes) as a colorless oil (0.18 g, 49% 
yield): 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.18 (m, 5H), 5.76 – 5.68 (m, 1H), 4.58 (dd, 
J = 7.2, 1.1 Hz, 2H), 3.79 (s, 3H), 2.13 (q, J = 1.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
δ 155.8, 143.8, 140.3, 128.4, 127.8, 127.6, 120.5, 65.8, 54.8, 25.6; IR (Neat Film, NaCl) 
3023, 2956, 1748, 1494, 1441, 1382, 1350, 1263, 1024, 944, 792, 765, 702 cm-1; HRMS 





(E)-3-(4-(((Methoxycarbonyl)oxy)methyl)phenyl)but-2-en-1-yl methyl carbonate (6f). 
Carbonate 6f was prepared from SI-1 according to Representative Procedure #2 and 
isolated by silica gel flash column chromatography (5% EtOAc/hexanes) as a colorless 
solid (0.11 g, 46% yield): 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.31 (m, 4H), 5.98 – 5.88 
(m, 1H), 5.15 (s, 2H), 4.85 (dd, J = 7.0, 0.9 Hz, 2H), 3.802 (s, 3H), 3.795 (s, 3H), 2.13 – 
2.10 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 156.0, 155.9, 142.8, 140.6, 134.7, 128.5, 
126.3, 121.2, 69.4, 65.0, 55.1, 55.0, 16.4; IR (Neat Film, NaCl) 2959, 1754, 1443, 1385, 
1333, 1288, 958, 909, 794, 731 cm-1; HRMS (FAB+) m/z calc’d for C15H18O6 [M]+: 
















Methyl (E)-3-(3-bromophenyl)but-2-enoate (SI-2). Ester SI-2 was prepared from (3-
bromophenyl)boronic acid according to Representative Procedure #1 and isolated by silica 
gel flash column chromatography (3% EtOAc/hexanes) as a colorless oil (0.54 g, 42% 
yield): 1H NMR (400 MHz, CDCl3) δ 7.65 – 7.59 (m, 1H), 7.51 (ddd, J = 7.9, 2.0, 1.0 Hz, 
1H), 7.45 – 7.37 (m, 1H), 7.31 – 7.26 (m, 1H), 6.14 (q, J = 1.3 Hz, 1H), 3.78 (d, J = 1.2 
Hz, 3H), 2.57 (d, J = 1.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.1, 154.3, 144.4, 
132.1, 130.2, 129.6, 125.1, 122.8, 117.9, 51.4, 18.1; IR (Neat Film, NaCl) 3062, 2948, 
1719, 1631, 1558, 1435, 1346, 1274, 1191, 1168, 1037, 869, 785, 688 cm-1; HRMS (FAB+) 





(E)-3-(3-Bromophenyl)but-2-en-1-yl methyl carbonate (6g). Carbonate 6g was prepared 
from SI-2 according to Representative Procedure #2 and isolated by silica gel flash column 
chromatography (5% EtOAc/hexanes) as a colorless oil (0.47 g, 78% yield): 1H NMR (400 
MHz, CDCl3) δ 7.54 (t, J = 1.8 Hz, 1H), 7.40 (ddd, J = 7.9, 1.9, 1.0 Hz, 1H), 7.32 (ddd, J 
= 7.8, 1.8, 1.0 Hz, 1H), 7.22 – 7.14 (m, 1H), 5.96 – 5.88 (m, 1H), 4.88 – 4.76 (m, 2H), 3.81 
(s, 3H), 2.12 – 2.08 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 155.93, 144.65, 139.74, 
130.68, 129.96, 129.18, 124.64, 122.65, 122.08, 64.84, 55.02, 16.38; IR (Neat Film, NaCl) 
2955, 1748, 1590, 1558, 1442, 1376, 1332, 1263, 946, 789, 690 cm-1; HRMS (FAB+) m/z 





(E)-Methyl (3-(3-nitrophenyl)but-2-en-1-yl) carbonate (6h). Carbonate 6h was 
prepared from methyl (E)-3-(3-nitrophenyl)but-2-enoate8 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (10% 
EtOAc/hexanes) as a colorless oil (0.47 g, 78% yield): 1H NMR (400 MHz, CDCl3) δ 8.26 
(t, J = 2.0 Hz, 1H), 8.14 (ddd, J = 8.2, 2.3, 1.0 Hz, 1H), 7.73 (ddd, J = 7.8, 1.8, 1.1 Hz, 
1H), 7.51 (t, J = 8.0 Hz, 1H), 6.10 – 5.91 (m, 1H), 4.88 (dt, J = 6.9, 0.8 Hz, 2H), 3.82 (s, 
3H), 2.18 (dd, J = 1.4, 0.7 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 155.9, 148.5, 144.1, 
138.7, 131.9, 129.4, 123.6, 122.5, 121.0, 64.7, 55.1, 16.4; IR (Neat Film, NaCl) 3108, 3026, 
2969, 2868, 1750, 1530, 1443, 1384, 1353, 1279, 1096, 994, 949, 930, 876, 788, 736, 682 













(E)-methyl (3-(Naphthalen-2-yl)but-2-en-1-yl) carbonate (6i). Carbonate 6i was 
prepared from methyl (E)-3-(naphthalen-2-yl)but-2-enoate10 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) 
as a colorless oil (0.26 g, 51% yield): 1H NMR (400 MHz, CDCl3) δ 7.86 – 7.77 (m, 4H), 
7.58 (dd, J = 8.6, 1.9 Hz, 1H), 7.52 – 7.42 (m, 2H), 6.12 – 6.05 (m, 1H), 4.92 (dq, J = 7.0, 
0.7 Hz, 2H), 3.82 (s, 3H), 2.29 – 2.22 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 156.0, 140.9, 
139.7, 133.4, 133.0, 128.3, 128.0, 127.7, 126.4, 126.1, 124.9, 124.3, 121.3, 65.2, 55.0, 16.5; 
IR (Neat Film, NaCl) 3057, 2952, 1752, 1740, 1596, 1467, 1442, 1382, 1248, 997, 941, 






(E)-3-(3,5-Dimethylphenyl)but-2-en-1-yl methyl carbonate (6k). Carbonate 6k was 
prepared from methyl (E)-3-(3,5-dimethylphenyl)but-2-enoate11 according to 
Representative Procedure #2 and isolated by silica gel flash column chromatography (5% 
EtOAc/hexanes) as a colorless oil (0.32 g, 86% yield): 1H NMR (400 MHz, CDCl3) δ 7.02 
(dt, J = 1.6, 0.8 Hz, 2H), 6.93 (td, J = 1.6, 0.8 Hz, 1H), 5.96 – 5.82 (m, 1H), 4.84 (dd, J = 
7.0, 0.8 Hz, 2H), 3.80 (s, 3H), 2.31 (d, J = 0.7 Hz, 6H), 2.15 – 2.06 (m, 3H); 13C NMR (101 
MHz, CDCl3) δ 156.0, 142.6, 141.5, 137.9, 129.4, 123.9, 120.4, 65.1, 54.9, 21.5, 16.5; IR 
(Neat Film, NaCl) 2956, 2918, 2862, 1748, 1601, 1443, 1376, 1335, 1262, 944, 905, 849, 





(E)-Methyl (3-phenylhept-2-en-1-yl) carbonate (8b). Carbonate 8b was prepared from 
ethyl (E)-3-phenylhept-2-enoate12 according to Representative Procedure #2 and isolated 
by silica gel flash column chromatography (5% EtOAc/hexanes) as a colorless oil (0.31 g, 
58% yield): 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.27 (m, 5H), 5.89 – 5.71 (m, 1H), 4.84 
(d, J = 7.0 Hz, 2H), 3.80 (s, 3H), 2.73 – 2.46 (m, 2H), 1.41 – 1.24 (m, 4H), 1.06 – 0.73 (m, 
3H); 13C NMR (101 MHz, CDCl3) δ 156.0, 146.6, 142.0, 128.4, 127.6, 126.6, 121.1, 65.0, 
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1493, 1444, 1378, 1344, 1262, 1129, 941, 792, 766, 698 cm-1; HRMS (FAB+) m/z calc’d 





(E)-Methyl (4-methyl-3-phenylpent-2-en-1-yl) carbonate (8c). Carbonate 8c was 
prepared from ethyl (E)-4-methyl-3-phenylpent-2-enoate13 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) 
as a colorless oil (0.17 g, 17% yield): 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 3H), 
7.11 – 7.02 (m, 2H), 5.61 (td, J = 7.0, 1.3 Hz, 1H), 4.46 (dd, J = 7.0, 0.8 Hz, 2H), 3.75 (s, 
3H), 2.66 – 2.54 (m, 1H), 1.03 (d, J = 6.8 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 155.8, 
154.0, 139.7, 128.5, 128.2, 127.3, 117.8, 66.1, 54.8, 36.0, 21.5; IR (Neat Film, NaCl) 2961, 
2872, 1749, 1492, 1442, 1263, 942, 792, 771, 703 cm-1; HRMS (FAB+) m/z calc’d for 





(E)-3-(Cyclohex-1-en-1-yl)but-2-en-1-yl methyl carbonate (8e). Carbonate 8e was 
prepared from ethyl (E)-3-(cyclohex-1-en-1-yl)but-2-enoate14 according to Representative 
Procedure #2 and isolated by silica gel flash column chromatography (5% EtOAc/hexanes) 
as a colorless oil (0.25 g, 73% yield): 1H NMR (400 MHz, CDCl3) δ 6.00 – 5.92 (m, 1H), 
5.68 – 5.55 (m, 1H), 4.79 (d, J = 7.0 Hz, 2H), 3.78 (s, 3H), 2.16 (ddd, J = 12.0, 5.9, 3.7 Hz, 
4H), 1.85 (d, J = 1.1 Hz, 3H), 1.73 – 1.49 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 156.0, 
141.2, 137.0, 126.0, 116.8, 65.5, 54.9, 26.1, 25.8, 23.0, 22.3, 14.1; IR (Neat Film, NaCl) 
2929, 2859, 1749, 1638, 1443, 1263, 1119, 940, 792 cm-1; HRMS (FAB+) m/z calc’d for 
C12H18O3 [M]+: 210.1256, found 210.1252. 
 




(S)-2-(Methoxymethoxy)-2-(2-phenylbut-3-en-2-yl)malononitrile (3). In a nitrogen-
filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 
(1.3 mg, 0.0020 mmol, 2 mol %), ligand (Sa)-L3 (2.5 mg, 0.0042 mmol, 4.2 mol %), TBD 
(1.4 mg, 0.010 mmol, 10 mol %), and THF (0.5 mL). Vial A was stirred at 25 °C (ca. 10 
min) while another 1 dram vial (vial B) was charged with MAC nucleophile 1 (0.10 mmol 
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pre-formed catalyst solution (vial A) was then transferred to vial B followed immediately 
by carbonate 2 (0.20 mmol, 0.10 mmol, or 0.12 mmol, as specified). The vial was sealed 
and stirred at 60 °C. After 18 h, the vial was removed from the glove box and filtered 
through a pad of silica, rinsing with EtOAc. The crude mixture was concentrated and 
1,2,4,5-tetrachloro-3-nitrobenzene (0.10 mmol in 0.5 mL CDCl3) was added. The NMR 
yield (measured in reference to 1,2,4,5-tetrachloro-3-nitrobenzene δ 7.74 ppm (s, 1H)) was 
determined by 1H NMR analysis of the crude mixture. The residue was purified by 
preparatory TLC (15% EtOAc/hexanes) to afford MAC adduct product 3 as a colorless oil. 
For the purposes of characterization, product 3 was further purified by preparatory HPLC 
(20% EtOAc/hexanes, Viridis SFC 2-Ethylpyridine 5 µm column, flow rate = 1.5 mL/min; 
λ = 230 nm): 94% ee (entry 9); [α]D25 +11.7 (c 0.07, CHCl3) (entry 9); 1H NMR (400 MHz, 
CDCl3) δ 7.61 – 7.54 (m, 2H), 7.42 – 7.32 (m, 3H), 6.51 (dd, J = 17.4, 11.0 Hz, 1H), 5.59 
– 5.34 (m, 2H), 5.02 (s, 2H), 3.42 (s, 3H), 1.84 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
138.3, 137.6, 129.0, 128.57, 238.55, 128.3, 125.2, 119.2, 112.8, 112.7, 96.7, 73.9, 57.5, 
52.8, 20.9; IR (Neat Film, NaCl) 3062, 2957, 2896, 2242, 2189, 1750, 1492, 1445, 1358, 
1268, 1161, 1108, 1030, 930, 751, 698 cm-1; HRMS (ESI+) m/z calc’d for C15H17N2O2 
[M+H]+: 257.1290, found 257.1313; HPLC conditions: 1% IPA, 1.0 mL/min, Chiralpak 
IC column, λ = 210 nm, tR (min): major = 13.303, minor = 17.243. 
 
 
General Procedure for the Enantioenriched Carboxylic Acid Synthesis 
 
Please note that the absolute configuration was determined only for compound 7h via x-
ray crystallographic analysis. The absolute configuration for all other products has been 




(S)-2-Methyl-2-phenylbut-3-enoic acid (7a). In a nitrogen-filled glove box, to a 1 dram 
vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 0.0040 mmol, 2 mol 
%), ligand (Sa)-L3 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD (2.8 mg, 0.020 mmol, 10 mol 
%), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 1 dram vial 
(vial B) was charged with MAC nucleophile 1 (25 mg, 0.20 mmol, 100 mol %), THF (1 
mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed catalyst solution (vial A) was then 
transferred to vial B followed immediately by carbonate 2 (83 mg, 0.40 mmol, 200 mol 
%). The vial was sealed and stirred at 60 °C. After 18 h or 48 h, the vial was removed from 
the glove box, transferred to a 20 mL vial with CH2Cl2, and concentrated. The crude 
material was heated at 80 °C in 6M HCl (4 mL) for 18 h. Whereupon, the reaction mixture 
was cooled to 0 °C and basified with 6M NaOH (4.5 mL). The aqueous layer was extracted 
with CH2Cl2 (4 x 8 mL). The combined organic layers were washed with 2M NaOH (8 
mL). The combined aqueous layers were acidified with concentrated HCl, extracted with 
CH2Cl2 (4 x 8 mL), dried over Na2SO4, and concentrated under reduced pressure at 0 °C to 
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CHCl3); HPLC conditions: 2% IPA, 1.0 mL/min, Chiralpak AD–H column, λ = 210 nm, 
tR (min): major = 12.198, minor = 11.426. Characterization data match those reported in 
the literature.15 Please note Compounds 7i, 7j, 7k, and 9a–9g were prepared at the same 
concentration with double catalyst loadings. 
 




(S)-2-(4-Chlorophenyl)-2-methylbut-3-enoic acid (7b). Product 7b was prepared 
according to the general procedure to give a pale yellow oil (33 mg, 80% yield): 93% ee; 
[α]D25 +8.1 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.24 (m, 4H), 6.38 (dd, J 
= 17.5, 10.7 Hz, 1H), 5.44 – 5.16 (m, 2H), 1.66 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.4, 141.1, 140.1, 133.3, 128.7, 128.3, 116.1, 53.3, 23.3; IR (Neat Film, NaCl) 3089, 
2987, 2645, 2539, 1705, 1493, 1400, 1282, 1097, 1014, 928, 826, 755 cm-1; HRMS (FAB+) 
m/z calc’d for C11H12O2Cl [M+H]+: 211.0526, found 211.0528; HPLC conditions: 2% IPA, 






(S)-2-(4-Fluorophenyl)-2-methylbut-3-enoic acid (7c). Product 7c was prepared 
according to the general procedure to give a pale yellow oil (35 mg, 90% yield): 90% ee; 
[α]D25 +3.4 (c 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.19 (m, 2H), 7.05 (t, J = 
8.7 Hz, 2H), 6.39 (dd, J = 17.5, 10.7 Hz, 1H), 5.42 – 5.14 (m, 2H), 1.67 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 180.6, 163.2, 160.7, 140.4, 138.3 (d, J = 3.4 Hz), 128.5 (d, J = 8.1 
Hz), 115.9, 115.5, 115.3, 53.2, 23.5; IR (Neat Film, NaCl) 3088, 2987, 2924, 2642, 1704, 
1603, 1510, 1462, 1412, 1277, 1234, 1165, 928, 833, 816, 735 cm-1; HRMS (FAB+) m/z 
calc’d for C11H12FO2 [M+H]+: 195.0833, found 195.0841; HPLC conditions: 2% IPA, 1.0 
















(S)-2-Methyl-2-(4-(trifluoromethyl)phenyl)but-3-enoic acid (7d). Product 7d was 
prepared according to the general procedure to give a pale yellow oil (41 mg, 83% yield): 
92% ee; [α]D25 –2.2 (c 2.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.60 (dt, J = 8.1, 0.8 Hz, 
2H), 7.45 (dt, J = 8.3, 0.8 Hz, 2H), 6.38 (dd, J = 17.5, 10.7 Hz, 1H), 5.48 – 5.09 (m, 2H), 
1.68 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 179.0, 146.6, 139.7, 129.6, 130.0, 129.5, 
127.2, 125.6 (q, J = 3.7 Hz), 122.8, 116.6, 53.7, 29.9, 23.4; IR (Neat Film, NaCl) 2926, 
2649, 1707, 1618, 1413, 1328, 1277, 1167, 1126, 1081, 1016, 930, 940 cm-1; HRMS 
(FAB+) m/z calc’d for C12H12O2F3 [M+H]+: 245.0789, found 245.0794; SFC conditions: 
2% IPA, 2.5 mL/min, Chiralpak AD–H column, λ = 210 nm, tR (min): major = 13.592, 





(S)-2-Methyl-2-(p-tolyl)but-3-enoic acid (7e). Product 7e was prepared according to the 
general procedure to give a pale yellow oil (24 mg, 63% yield): 94% ee; [α]D25 +4.6 (c 0.8, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.01 (m, 4H), 6.40 (dd, J = 17.5, 10.7 Hz, 
1H), 5.59 – 5.08 (m, 2H), 2.34 (s, 3H), 1.64 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 181.0, 
140.7, 139.8, 137.0, 129.3, 126.6, 115.4, 53.3, 23.3, 21.1; IR (Neat Film, NaCl) 2986, 1702, 
1636, 1512, 1457, 1412, 1276, 1191, 1132, 1077, 1020, 925, 815, 730 cm-1; HRMS (ESI-
) m/z calc’d for C12H13O2 [M-H]-: 189.0916, found 189.0903; HPLC conditions: 2% IPA, 






(S)-2-(4-(Hydroxymethyl)phenyl)-2-methylbut-3-enoic acid (7f). Product 7f was 
prepared according to the general procedure and isolated by preparatory TLC (30% 
acetone/hexanes) to give a colorless soild (21 mg, 51% yield): 95% ee; [α]D25 +3.4 (c 0.5, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.33 (q, J = 8.2 Hz, 4H), 6.37 (dd, J = 17.5, 10.7 
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180.1, 143.2, 140.4, 136.4, 128.8, 127.2, 115.8, 53.6, 45.9, 23.4; IR (Neat Film, NaCl) 
2985, 2927, 2642, 1703, 1636, 1512, 1460, 1268, 1182, 1076, 926, 836, 731, 683 cm-1; 
HRMS (FAB+) m/z calc’d for C12H15O3 [M+H]+: 207.1021, found 207.1025; HPLC 
conditions: 2% IPA, 1.0 mL/min, Chiralpak AD–H column, λ = 210 nm, tR (min): major = 





(S)-2-(3-Bromophenyl)-2-methylbut-3-enoic acid (7g). Product 7g was prepared 
according to the general procedure to give a pale yellow oil (35 mg, 69% yield): 92% ee; 
[α]D25 –2.6 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.47 (t, J = 1.9 Hz, 1H), 7.41 
(ddd, J = 7.6, 1.9, 1.2 Hz, 1H), 7.29 – 7.18 (m, 2H), 6.35 (dd, J = 17.5, 10.7 Hz, 1H), 5.42 
– 5.09 (m, 2H), 1.65 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 179.7, 145.0, 139.8, 130.5, 
130.2, 129.9, 125.5, 122.8, 116.4, 53.5, 23.3; IR (Neat Film, NaCl) 2987, 2644, 1705, 1593, 
1566, 1475, 1413, 1280, 1129, 1070, 997, 928, 785, 760, 700 cm-1; HRMS (ESI-) m/z 
calc’d for C11H10O2Br [M-H]-: 252.9864, found 252.9864; HPLC conditions: 2% IPA, 1.0 





(S)-2-Methyl-2-(3-nitrophenyl)but-3-enoic acid (7h). Product 7h was prepared 
according to the general procedure to give a colorless solid (41 mg, 93% yield): 87% ee; 
[α]D25 +94.5 (c 3.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.22 (t, J = 2.0 Hz, 1H), 8.15 
(ddd, J = 8.2, 2.2, 1.0 Hz, 1H), 7.69 (ddd, J = 7.9, 1.9, 1.1 Hz, 1H), 7.53 (t, J = 8.0 Hz, 
1H), 6.38 (dd, J = 17.5, 10.7 Hz, 1H), 5.59 – 5.11 (m, 2H), 1.72 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 179.6, 148.5, 144.7, 139.2, 133.3, 129.6, 122.5, 122.1, 117.2, 53.7, 23.4; 
IR (Neat Film, NaCl) 3089, 2988, 2924, 2641, 1707, 1530, 1351, 1276, 1106, 929, 808, 
738, 688 cm-1; HRMS (FAB+) m/z calc’d for C11H12O4N [M+H]+: 222.0766, found 
222.0769; HPLC conditions: 3% IPA, 1.0 mL/min, Chiralpak AD–H column, λ = 210 nm, 















(S)-2-Methyl-2-(naphthalen-2-yl)but-3-enoic acid (7i). Product 7i was prepared 
according to the general procedure to give a pale yellow oil (30 mg, 66% yield): 92% ee; 
[α]D25 +7.8 (c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.91 – 7.72 (m, 4H), 7.55 – 7.39 
(m, 3H), 6.52 (dd, J = 17.5, 10.7 Hz, 1H), 5.57 – 5.11 (m, 2H), 1.77 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 180.9, 140.5, 140.0, 133.3, 132.5, 128.3, 128.2, 127.6, 126.3, 126.2, 125.3, 
125.2, 116.0, 53.9, 23.4; IR (Neat Film, NaCl) 3057, 2984, 1701, 1506, 1458, 1411, 1274, 
1182, 1128, 1102, 925, 856, 816, 747 cm-1; HRMS (FAB+) m/z calc’d for C15H14O2 [M]+: 
226.0994, found 226.0992; HPLC conditions: 2% IPA, 1.0 mL/min, Chiralpak AD–H 





(S)-2-Methyl-2-(m-tolyl)but-3-enoic acid (7j). Product 7j was prepared according to the 
general procedure to give a pale yellow oil (26 mg, 68% yield): 93% ee; [α]D25 +5.2 (c 1.6, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.25 – 7.04 (m, 4H), 6.40 (dd, J = 17.5, 10.7 Hz, 
1H), 5.45 – 5.08 (m, 2H), 2.44 – 2.20 (m, 3H), 1.65 (s, 3H); 13C NMR (101 MHz, CDCl3) 
δ 180.2, 142.7, 140.6, 138.3, 128.5, 128.1, 127.3, 123.7, 115.6, 53.6, 23.3, 21.7; IR (Neat 
Film, NaCl) 2984, 2923, 2648, 1703, 1606, 1459, 1411, 1275, 1178, 1127, 1002, 926, 785, 
703 cm-1; HRMS (FAB+) m/z calc’d for C12H15O2 [M+H]+: 191.1072, found 191.1074; 
HPLC conditions: 2% IPA, 1.0 mL/min, Chiralpak AD–H column, λ = 210 nm, tR (min): 





(S)-2-(3,5-Dimethylphenyl)-2-methylbut-3-enoic acid (7k). Product 7k was prepared 
according to the general procedure and isolated by preparatory TLC (30% 
acetone/hexanes) to give a colorless oil (13 mg, 32% yield): 85% ee; [α]D25 –40.6 (c 0.1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.94 (d, J = 8.5 Hz, 3H), 6.42 (dd, J = 17.4, 10.6 
Hz, 1H), 5.45 – 5.08 (m, 2H), 2.33 (s, 6H), 1.65 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.5, 142.8, 140.8, 138.1, 129.0, 124.4, 115.3, 53.6, 23.3, 21.6; IR (Neat Film, NaCl) 
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calc’d for C13H17O2 [M+H]+: 205.1229, found 205.1233; HPLC conditions: 2% IPA, 1.0 
mL/min, Chiralpak AD–H column, λ = 210 nm, tR (min): major = 11.107, minor = 10.064. 
Please note an HMBC has been included due to the low intensity of the carbonyl 13C shift 





(S)-2-Ethyl-2-phenylbut-3-enoic acid (9a). Product 9a was prepared according to the 
general procedure and isolated by preparatory TLC (30% acetone/hexanes) to give a a 
colorless oil (23 mg, 61% yield): 92% ee; [α]D25 +17.4 (c 0.4, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.38 – 7.22 (m, 5H), 6.36 (dd, J = 17.7, 10.9 Hz, 1H), 5.35 (d, J = 10.7 Hz, 1H), 
5.09 (d, J = 17.6 Hz, 1H), 2.36 – 2.00 (m, 2H), 0.87 (t, J = 7.2 Hz, 3H).; 13C NMR (101 
MHz, CDCl3) δ 180.1, 141.3, 139.1, 128.4, 127.6, 127.2, 116.9, 58.0, 29.4, 9.4; IR (Neat 
Film, NaCl) 3060, 2970, 2928, 2636, 1702, 1495, 1448, 1407, 1381, 1261, 1083, 924, 761, 
700 cm-1; HRMS (FAB+) m/z calc’d for C12H15O2 [M+H]+: 191.1072, found 191.1071; 
HPLC conditions: 1.5% IPA, 1.0 mL/min, two Chiralpak AD–H columns in series, λ = 210 





(S)-2-Phenyl-2-vinylhexanoic acid (9b). Product 9b was prepared according to the 
general procedure and isolated by preparatory TLC (30% acetone/hexanes) to give a 
colorless oil (6 mg, 14% yield): 95% ee; [α]D25 –106.0 (c 0.07, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.40 – 7.29 (m, 5H), 6.38 (dd, J = 17.6, 10.9 Hz, 1H), 5.32 (dd, J = 10.9, 
0.9 Hz, 1H), 5.06 (dd, J = 17.6, 0.9 Hz, 1H), 2.28 – 1.98 (m, 2H), 1.44 – 1.14 (m, 4H), 0.87 
(t, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 178.4, 141.6, 139.7, 128.4, 127.5, 127.1, 
116.6, 57.5, 36.5, 27.0, 23.4, 14.1; IR (Neat Film, NaCl) 2956, 2920, 2851, 1734, 1706, 
1466, 1378, 1260, 1098, 925, 800, 722, 700 cm-1; HRMS (FAB+) m/z calc’d for C14H19O2 
[M+H]+: 219.1385, found 219.1291; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak AD–

















(R)-2-Methyl-2-phenethylbut-3-enoic acid (9f). Product 9f was prepared according to the 
general procedure and isolated by preparatory TLC (33% acetone/hexanes) to give a 
colorless oil (13 mg, 32% yield): 3% ee; [α]D25 –12.1 (c 0.7, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.44 – 7.04 (m, 5H), 6.10 (dd, J = 17.6, 10.7 Hz, 1H), 5.21 (dd, J = 14.0, 3.3 Hz, 
2H), 2.60 (dt, J = 11.0, 4.9 Hz, 2H), 2.33 – 1.79 (m, 2H), 1.40 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 182.0, 142.0, 140.9, 128.54, 128.49, 126.1, 114.7, 48.7, 41.1, 31.2, 20.7; IR (Neat 
Film, NaCl) 3026, 2927, 1702, 1496, 1454, 1380, 1264, 1097, 925, 748, 700 cm-1; HRMS 
(FAB+) m/z calc’d for C13H17O2 [M+H]+: 267.1385, found 267.1376; HPLC conditions: 
2% IPA, 1.0 mL/min, Chiralpak AD–H column, λ = 210 nm, tR (min): major = 18.485, 
minor = 14.652. Please note an HMBC has been included due to the low intensity of the 





2,2-Dimethylbut-3-enoic acid (9g). Product 9g was prepared according to the general 
procedure to give a colorless oil (15 mg, 63% yield). Characterization data match those 
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Determination of Enantiomeric Excess 
 
Please note racemic products were synthesized using racemic L3. 
 
Table S1: Determination of Enantiomeric Excess 
S15













































































Experimental Procedures and Spectroscopic Data for the One-pot Syntheses of 




Methyl (S)-2-(4-chlorophenyl)-2-methylbut-3-enoate (10). In a nitrogen-filled glove 
box, to a scintillation vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (13 mg, 
0.02 mmol, 2 mol %), ligand (Sa)-L3 (25 mg, 0.042 mmol, 4.2 mol %), TBD (14 mg, 0.10 
mmol, 10 mol %), and THF (5 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 
scintillation vial (vial B) was charged with MAC nucleophile 1 (126 mg, 1.0 mmol, 100 
mol %), THF (5 mL), and BEt3 (2.0 mL, 1M in hexanes). The pre-formed catalyst solution 
(vial A) was then transferred to vial B followed immediately by carbonate 6b (480 mg, 2.0 
mmol, 200 mol %). The vial was sealed and stirred at 60 °C. After 18 h, the vial was 
removed from the glove box and the reaction mixture was concentrated under reduced 
pressure.  
 
To the vial of crude MAC adduct equipped with a stir bar and septum cap was added 1:1 
AcOH/DME (2 mL, 0.5 M) and CSA (0.26 g, 1.1 mmol, 1.1 equiv) under a nitrogen 
atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction mixture was 
cooled to ambient temperature, diluted with anhydrous MeOH (2.8 mL), and cooled to –
40 °C. A solution of 1:1 MeOH/Et3N (5.6 mL, 20.1 equiv of Et3N) was added dropwise 
over 10 min. The reaction mixture was allowed to warm to ambient temperature over 18 h, 
whereupon the reaction was slowly quenched with saturated NH4Cl aqueous solution (5 
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organic layers were washed with brine (10 mL), dried over Na2SO4, and concentrated under 
reduced pressure at 0 °C. The crude residue was purified by silica gel flash column 
chromatography (10% EtOAc/hexanes) to give methyl ester 10 as a colorless oil (0.20 g, 
88% yield): [α]D25 +1.5 (c 0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.41 – 6.99 (m, 4H), 
6.35 (dd, J = 17.5, 10.7 Hz, 1H), 5.48 – 5.00 (m, 2H), 3.70 (s, 3H), 1.62 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 175.0, 142.0, 140.6, 132.9, 128.7, 128.1, 115.6, 53.5, 52.7, 23.7; IR 
(Neat Film, NaCl) 2986, 2952, 1734, 1637, 1493, 1459, 1246, 1181, 1123, 1098, 1014, 






Allyl (S)-2-(4-chlorophenyl)-2-methylbut-3-enoate (11). In a nitrogen-filled glove box, 
to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 0.0040 
mmol, 2 mol %), ligand (Sa)-L3 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD (2.8 mg, 0.020 
mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while another 
1 dram vial (vial B) was charged with MAC nucleophile 1 (25 mg, 0.20 mmol, 100 mol 
%), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed catalyst solution (vial 
A) was then transferred to vial B followed immediately by carbonate 6b (96 mg, 0.40 
mmol, 200 mol %). The vial was sealed and stirred at 60 °C. After 18 h, the vial was 
removed from the glove box, transferred to a 20 mL vial with CH2Cl2, and concentrated. 
 
To the vial of crude MAC adduct equipped with a stir bar and septum cap was added 1:1 
AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a nitrogen 
atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction mixture was 
cooled to ambient temperature, diluted with allyl alcohol (0.4 mL), and cooled to 0 °C. A 
solution of 1:1 Et3N/allyl alcohol (1.1 mL, 20.4 equiv of Et3N) was added dropwise over 
10 min. The reaction mixture was allowed to warm to ambient temperature over 18 h, 
whereupon the reaction was slowly quenched with saturated NH4Cl aqueous solution (5 
mL). The aqueous layer was then extracted with CH2Cl2 (3 x 10 mL) and the combined 
organic layers were washed with brine (10 mL), dried over Na2SO4, and concentrated under 
reduced pressure at 0 °C. The crude residue was purified by preparatory TLC (8% 
EtOAc/hexanes) to give allyl ester 11 as a colorless oil (37 mg, 74% yield): [α]D25 +0.4 (c 
2.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.12 (m, 4H), 6.36 (dd, J = 17.5, 10.7 
Hz, 1H), 5.85 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.38 – 5.02 (m, 4H), 4.61 (dt, J = 5.6, 1.4 
Hz, 2H), 1.63 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 174.1, 142.0, 140.6, 132.9, 131.9, 
128.6, 128.1, 118.5, 115.6, 65.9, 53.5, 23.6; IR (Neat Film, NaCl) 3089, 2985, 2930, 2857, 
1900, 1734, 1638, 1493, 1236, 1177, 1122, 1097, 1014, 926, 828, 756 cm-1; HRMS (FAB+) 











(S)-2-(4-Chlorophenyl)-2-methyl-1-(pyrrolidin-1-yl)but-3-en-1-one (12). In a nitrogen-
filled glove box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 
(2.7 mg, 0.0040 mmol, 2 mol %), ligand (Sa)-L3 (4.9 mg, 0.0084 mmol, 4.2 mol %), TBD 
(2.8 mg, 0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 
min) while another 1 dram vial (vial B) was charged with MAC nucleophile 1 (25 mg, 0.20 
mmol, 100 mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed 
catalyst solution (vial A) was then transferred to vial B followed immediately by carbonate 
6b (96 mg, 0.40 mmol, 200 mol %). The vial was sealed and stirred at 60 °C. After 18 h, 
the vial was removed from the glove box, transferred to a 20 mL vial with CH2Cl2, and 
concentrated. 
 
To the vial of crude MAC adduct equipped with a stir bar and septum cap was added 1:1 
AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a nitrogen 
atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction mixture was 
cooled to ambient temperature, diluted with CH2Cl2 (0.4 mL), and cooled to –40 °C. A 
solution of 1:1 pyrrolidine/CH2Cl2 (0.67 mL, 20.4 equiv of pyrrolidine) was added 
dropwise over 10 min then Et3N (0.57 mL, 4.1 mmol, 20.4 equiv). The reaction mixture 
was allowed to warm to ambient temperature over 18 h, whereupon the reaction was slowly 
quenched with saturated NH4Cl aqueous solution (5 mL). The aqueous layer was then 
extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were washed with 
brine (10 mL), dried over Na2SO4, and concentrated under reduced pressure at 0 °C. The 
crude residue was purified by preparatory TLC (30% acetone/hexanes) to give amide 12 
as a colorless oil (32 mg, 61% yield): [α]D25 –49.5 (c 1.7, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.34 – 7.28 (m, 2H), 7.21 – 7.14 (m, 2H), 6.45 (dd, J = 17.4, 10.7 Hz, 1H), 5.27 
(dd, J = 10.7, 0.8 Hz, 1H), 5.10 (dd, J = 17.4, 0.8 Hz, 1H), 3.63 – 3.47 (m, 2H), 2.98 (dt, J 
= 10.6, 6.3 Hz, 1H), 2.52 (dt, J = 10.6, 6.7 Hz, 1H), 1.78 – 1.62 (m, 2H), 1.64 – 1.55 (m, 
5H); 13C NMR (101 MHz, CDCl3) δ 172.1, 143.2, 139.7, 132.5, 129.0, 127.6, 115.5, 54.3, 
47.52, 47.44, 28.4, 26.5, 23.5; IR (Neat Film, NaCl) 2928, 2873, 1742, 1627, 1491, 1396, 
1228, 1185, 1096, 1012, 921, 829, 723 cm-1; HRMS (FAB+) m/z calc’d for C15H19ClNO 





(S)-N-allyl-2-(4-chlorophenyl)-2-methylbut-3-enamide (13). In a nitrogen-filled glove 
box, to a 1 dram vial (vial A) equipped with a stir bar was added [Ir(cod)Cl]2 (2.7 mg, 
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0.020 mmol, 10 mol %), and THF (1 mL). Vial A was stirred at 25 °C (ca. 10 min) while 
another 1 dram vial (vial B) was charged with MAC nucleophile 1 (25 mg, 0.20 mmol, 100 
mol %), THF (1 mL), and BEt3 (400 µL, 1M in hexanes). The pre-formed catalyst solution 
(vial A) was then transferred to vial B followed immediately by carbonate 6b (96 mg, 0.40 
mmol, 200 mol %). The vial was sealed and stirred at 60 °C. After 18 h, the vial was 
removed from the glove box, transferred to a 20 mL vial with CH2Cl2, and concentrated. 
 
To the vial of crude MAC adduct equipped with a stir bar and septum cap was added 1:1 
AcOH/DME (0.4 mL, 0.5 M) and CSA (51 mg, 0.22 mmol, 1.1 equiv) under a nitrogen 
atmosphere. The reaction was heated to 60 °C for 6 h, whereupon the reaction mixture was 
cooled to ambient temperature, diluted with allyl amine (0.4 mL), and cooled to 0 °C. A 
solution of 1:1 Et3N/allyl amine (1.1 mL, 20.4 equiv of Et3N) was added dropwise over 10 
min. The reaction mixture was allowed to warm to ambient temperature over 18 h, 
whereupon the reaction was slowly quenched with saturated NH4Cl aqueous solution (5 
mL). The aqueous layer was then extracted with CH2Cl2 (3 x 10 mL) and the combined 
organic layers were washed with brine (10 mL), dried over Na2SO4, and concentrated under 
reduced pressure at 0 °C. The crude residue was purified by preparatory TLC (30% 
EtOAc/hexanes) to give allyl amide 13 as a colorless oil (31 mg, 63% yield): [α]D25 +10.2 
(c 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.17 (m, 4H), 6.29 (dd, J = 17.4, 10.6 
Hz, 1H), 5.90 – 5.75 (m, 1H), 5.64 (s, 1H), 5.33 (dd, J = 10.6, 0.8 Hz, 1H), 5.20 – 5.03 (m, 
3H), 3.96 – 3.82 (m, 2H), 1.67 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 174.1, 142.0, 141.8, 
134.1, 133.1, 128.9, 128.8, 116.6, 116.5, 54.3, 42.3, 24.6; IR (Neat Film, NaCl) 3341, 3085, 
2983, 2931, 1739, 1658, 1520, 1493, 1414, 1270, 1096, 1014, 922, 827, 725, 657 cm-1; 
HRMS (FAB+) m/z calc’d for C14H17NOCl [M+H]+: 250.0999, found 250.0991. 
 




Methyl (S)-2-(4-chlorophenyl)-2-methylbutanoate (14). To a solution of olefin 10 (13 
mg, 0.056 mmol, 1 equiv) in EtOAc (1 mL) was added Pd/C (2.5 mg, 20% w/w). The 
reaction mixture was sparged with a hydrogen gas (balloon) for 5 minutes and then stirred 
under a hydrogen atmosphere for 18 h, whereupon the reaction was filtered through celite 
with EtOAc (5 mL) and concentrated under reduced pressure at 0 °C to give alkyl 14 as a 
colorless oil (12 mg, 97% yield): [α]D25 +3.6 (c 1.2, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.41 – 7.15 (m, 4H), 3.67 (s, 3H), 2.31 – 1.80 (m, 2H), 1.53 (s, 3H), 0.83 (t, J = 7.4 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 176.5, 142.4, 132.6, 128.6, 127.7, 52.3, 50.4, 32.0, 
22.2, 9.2; IR (Neat Film, NaCl) 2970, 2880, 1731, 1493, 1457, 1383, 1307, 1238, 1147, 
1096, 1012, 824, 756, 720 cm-1; HRMS (FAB+) m/z calc’d for C12H16O2Cl [M+H]+: 












(S)-2-(4-Chlorophenyl)-2-methylbut-3-en-1-ol (15). DIBAL (0.029 mL, 0.16 mmol, 3 
equiv) was added dropwise to a solution of methyl ester 10 (13 mg, 0.056 mmol, 1 equiv) 
in Et2O (1.0 mL) at 0 °C. The mixture was stirred at 0 °C for 2 h, whereupon the reaction 
was quenched with a saturated Rochelle’s salt aqueous solution (1 mL) and stirred for 18 
h at ambient temperature. The aqueous layer was then extracted with CH2Cl2 (3 x 5 mL) 
and the combined organic layers were washed with brine (5 mL), dried over Na2SO4, and 
concentrated under reduced pressure at 0 °C. The crude residue was purified by preparatory 
TLC (25% acetone/hexanes) to give alcohol 15 as a colorless oil (8 mg, 73% yield): [α]D25 





(3S)-3-(4-Chlorophenyl)-4-hydroxy-3-methyldihydrofuran-2(3H)-one (16). To a 
solution of olefin 10 (24 mg, 0.10 mmol, 1 equiv) in THF/H2O (4:1, 1 mL) was added 
K2OsO4 (4.0 mg, 0.010 mmol, 0.1 equiv) and N-methylmorpholine N-oxide (19 mg, 0.16 
mmol, 1.6 equiv). The reaction mixture was stirred for 18 h, whereupon the reaction was 
quenched with sodium sulfite (10 mg, 0.079 mmol, 0.79 equiv) and diluted with water (0.5 
mL). The aqueous layer was then extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were washed with brine (5 mL), dried over Na2SO4, and concentrated under 
reduced pressure at 0 °C. The crude residue was purified by preparatory TLC (30% 
acetone/hexanes) to give lactone 16 as a colorless oil (19 mg, 82% yield, 1:1 dr): [α]D25 –
115.6 (c 0.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.26 (m, 4H), 4.58 (dd, J = 4.4, 
2.8 Hz, 0.5H), 4.54 (dd, J = 10.2, 4.5 Hz, 0.5H), 4.35 – 4.31 (m, 0.5H), 4.28 – 4.20 (m, 
1H), 4.16 (dd, J = 10.1, 2.8 Hz, 0.5H), 1.66 (s, 1.5H), 1.57 (s, 1.5H); 13C NMR (101 MHz, 
CDCl3) δ 178.4, 178.1, 138.4, 134.4, 134.0, 133.9, 129.6, 129.4, 129.3, 127.8, 76.5, 76.2, 
71.8, 71.6, 53.2, 52.8, 22.3, 18.5; IR (Neat Film, NaCl) 3448, 2976, 2929, 1761, 1496, 
1384, 1218, 1178, 1096, 1072, 1014, 982, 927, 737, 688 cm-1; HRMS (FAB+) m/z calc’d 





Methyl (R)-2-(4-chlorophenyl)-2-methyl-3-oxopropanoate (17). A solution of olefin 10 













Shockley, ‡ Hethcox, ‡ and Stoltz*    Supporting Information 
 
CH2Cl2 (1:5, 2.6 mL) was cooled to –78 °C. Ozone was bubbled through the reaction 
mixture for 0.5 h, whereupon the reaction mixture was sparged with N2 and dimethyl 
sulfide (0.10 mL, 0.14 mmol, 3 equiv) was added. The cooling bath was then removed and 
the reaction was stirred for 18 h at ambient temperature. The reaction mixture was 
concentrated under reduced pressure at 0 °C and the crude residue was purified by 
preparatory TLC (17% Et2O/hexanes) to afford aldehyde 17 as a colorless oil (5.0 mg, 50% 
yield): [α]D25 +9.1 (c 0.07, CHCl3); 1H NMR (400 MHz, CDCl3) δ 9.83 (s, 1H), 7.41 – 7.33 
(m, 2H), 7.22 – 7.13 (m, 2H), 3.81 (s, 3H), 1.69 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
196.2, 171.8, 134.8, 134.5, 129.5, 128.5, 61.7, 53.1, 18.0; IR (Neat Film, NaCl) 2992, 2954, 
2845, 2726, 1721, 1596, 1494, 1455, 1252, 1122, 1096, 1013, 911, 823, 758, 718 cm-1; 
HRMS (FAB+) m/z calc’d for C11H12ClO3 [M+H]+: 227.0475, found 227.0479. 
 
Crystal Structure Data for Carboxylic Acid 7h 
 
Carboxylic acid 7h was recrystallized by slow evaporation of CH2Cl2 to provide crystals 




Table S2. Crystal data and structure refinement for 7h. 
Empirical formula  C11 H11 N O4 
Formula weight  221.21 
Temperature  200(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.3561(3) Å a= 90°. 
 b = 6.7600(3) Å b= 94.5940(10)°. 
 c = 10.9461(5) Å g = 90°. 
Volume 542.57(4) Å3 
Z 2 
Density (calculated) 1.354 Mg/m3 
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Absorption coefficient 0.879 mm-1 
F(000) 232 
Theta range for data collection 4.051 to 72.406°. 
Index ranges -9<=h<=9, -8<=k<=8, -13<=l<=13 
Reflections collected 24109 
Independent reflections 2132 [R(int) = 0.0427] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2132 / 1 / 146 
Goodness-of-fit on F2 1.315 
Final R indices [I>2sigma(I)] R1 = 0.0495, wR2 = 0.1336 
R indices (all data) R1 = 0.0497, wR2 = 0.1346 
Absolute structure parameter 0.08(5) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.312 and -0.539 e.Å-3 
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Table S3. Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 7h. U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C(1) 6927(3) 5263(3) 4602(2) 32(1) 
C(2) 7734(2) 5232(3) 5795(2) 30(1) 
C(3) 6640(2) 5267(3) 6762(2) 27(1) 
C(4) 4752(2) 5328(3) 6510(2) 33(1) 
C(5) 3969(2) 5364(3) 5309(2) 35(1) 
C(6) 5062(3) 5332(3) 4329(2) 34(1) 
C(7) 7495(2) 5394(3) 8089(2) 33(1) 
C(8) 7573(4) 7595(4) 8448(2) 52(1) 
C(9) 9331(3) 4360(5) 8210(2) 51(1) 
C(10) 10884(3) 5180(9) 8624(2) 86(2) 
C(11) 6291(2) 4290(3) 8935(2) 33(1) 
O(1) 6125(2) 2390(3) 8666(1) 46(1) 
O(2) 5572(2) 5042(3) 9776(1) 49(1) 
N(1) 8117(3) 5216(4) 3590(2) 47(1) 
O(3) 9753(2) 5210(6) 3825(2) 84(1) 
O(4) 7426(3) 5157(6) 2546(2) 81(1) 
________________________________________________________________________________ 
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Table S4. Bond lengths [Å] and angles [°] for 7h. 
_____________________________________________________  
C(1)-C(6)  1.381(3) 
C(1)-C(2)  1.390(2) 
C(1)-N(1)  1.466(3) 
C(2)-C(3)  1.380(2) 
C(3)-C(4)  1.395(2) 
C(3)-C(7)  1.538(2) 
C(4)-C(5)  1.392(3) 
C(5)-C(6)  1.391(3) 
C(7)-C(9)  1.517(3) 
C(7)-C(11)  1.527(2) 
C(7)-C(8)  1.539(3) 
C(9)-C(10)  1.318(4) 
C(11)-O(2)  1.210(2) 
C(11)-O(1)  1.321(3) 
N(1)-O(3)  1.210(3) 
































Table S5. Anisotropic displacement parameters  (Å2x 103) for 7h. The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
C(1) 38(1)  32(1) 26(1)  -1(1) 2(1)  1(1) 
C(2) 29(1)  34(1) 28(1)  0(1) 1(1)  0(1) 
C(3) 30(1)  25(1) 27(1)  1(1) 1(1)  -1(1) 
C(4) 30(1)  34(1) 35(1)  1(1) 4(1)  1(1) 
C(5) 29(1)  34(1) 41(1)  3(1) -5(1)  -1(1) 
C(6) 40(1)  28(1) 32(1)  -2(1) -8(1)  1(1) 
C(7) 31(1)  42(1) 26(1)  0(1) 3(1)  -4(1) 
C(8) 72(2)  48(1) 36(1)  -7(1) 6(1)  -24(1) 
C(9) 33(1)  91(2) 30(1)  16(1) 4(1)  5(1) 
C(10) 32(1)  176(5) 49(1)  35(2) -6(1)  -14(2) 
C(11) 33(1)  39(1) 26(1)  2(1) 1(1)  2(1) 
O(1) 62(1)  37(1) 42(1)  0(1) 22(1)  -4(1) 
O(2) 60(1)  51(1) 38(1)  -7(1) 22(1)  5(1) 
N(1) 50(1)  67(1) 26(1)  2(1) 4(1)  5(1) 
O(3) 40(1)  176(3) 36(1)  0(1) 9(1)  5(1) 
O(4) 66(1)  151(3) 25(1)  -7(1) -1(1)  12(1) 
______________________________________________________________________________ 
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Table S6. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 10 
3) for 7h. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2) 9023 5188 5942 36 
H(4) 3987 5347 7168 40 
H(5) 2680 5410 5158 42 
H(6) 4546 5355 3505 40 
H(8A) 8291 8322 7880 78 
H(8B) 8145 7730 9284 78 
H(8C) 6333 8135 8410 78 
H(9) 9363 3012 7967 62 
H(10A) 10911 6525 8877 103 
H(10B) 11978 4427 8671 103 
H(1) 5466 1842 9160 69 
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 13C NMR (101 MHz, CDCl3) of compound S1-1. 
 

















































































































































 13C NMR (101 MHz, CDCl3) of compound S1-2. 
 

































































































































































































 13C NMR (101 MHz, CDCl3) of compound 3. 
 















































































































































 13C NMR (101 MHz, CDCl3) of compound 4. 
 






































































































































































































 13C NMR (101 MHz, CDCl3) of compound 6c. 
 
























































































































































 13C NMR (101 MHz, CDCl3) of compound 6f. 
 





















































































































































 13C NMR (101 MHz, CDCl3) of compound 6g. 
 






















































































































































 13C NMR (101 MHz, CDCl3) of compound 6h. 
 






























































































































































 13C NMR (101 MHz, CDCl3) of compound 6i. 
 











































































































































 13C NMR (101 MHz, CDCl3) of compound 6k. 
 







































































































































 13C NMR (101 MHz, CDCl3) of compound 7b. 
 




















































































































































 13C NMR (101 MHz, CDCl3) of compound 7c. 
 

























































































































































 13C NMR (101 MHz, CDCl3) of compound 7d. 
 










































































































































 13C NMR (101 MHz, CDCl3) of compound 7e. 
 













































































































































































 13C NMR (101 MHz, CDCl3) of compound 7f. 
 



















































































































































 13C NMR (101 MHz, CDCl3) of compound 7g. 
 




















































































































































 13C NMR (101 MHz, CDCl3) of compound 7h. 
 































































































































































































 13C NMR (101 MHz, CDCl3) of compound 7i. 
 

















































































































































 13C NMR (101 MHz, CDCl3) of compound 7j. 
 












































































































































































 13C NMR (101 MHz, CDCl3) of compound 7k. 
 









































































































































































































































































 13C NMR (101 MHz, CDCl3) of compound 8b. 
 


























































































































































































 13C NMR (101 MHz, CDCl3) of compound 8c. 
 





















































































































































































 13C NMR (101 MHz, CDCl3) of compound 8e. 
 




















































































































































































 13C NMR (101 MHz, CDCl3) of compound 9a. 
 






























































































































































































 13C NMR (101 MHz, CDCl3) of compound 9b. 
 




















































































































































 13C NMR (101 MHz, CDCl3) of compound 9f. 
 








































































































































































































































































 13C NMR (101 MHz, CDCl3) of compound 10. 
 





























































































































































































 13C NMR (101 MHz, CDCl3) of compound 11. 
 











































































































































































































 13C NMR (101 MHz, CDCl3) of compound 12. 
 









































































































































































































 13C NMR (101 MHz, CDCl3) of compound 13. 
 














































































































































































 13C NMR (101 MHz, CDCl3) of compound 14. 
 


















































































































































































































 13C NMR (101 MHz, CDCl3) of compound 16. 
 












































































































































































 13C NMR (101 MHz, CDCl3) of compound 17. 
 
Infrared spectrum (Thin Film, NaCl) of compound 17. 
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